![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Bile Duct Cancer - 122 Studies Found
Suspended |
: Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer : Bile Duct Cancer : 2008-02-19 :
|
Suspended |
: A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer :
: 2011-03-15 : Drug: Fluorouracil implant Before the abdomen was closed, fluorouracil implant 1000mg was sprayed evenly |
Terminated |
: Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer :
: 2002-02-14 :
|
Completed |
: A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers :
: 2008-10-22 : Device: Probe-based confocal laser endomicroscopy ERCP with or without cholangiopancreatoscopy will be p |
Completed |
: Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma : Non-curative Resectable Bile Duct Carcinoma : 2009-11-16 : Drug: Temoporfin Drug treatment: Temoporfin 0.15 mg/kg bod |
Recruiting |
: Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours : Bile Duct Cancer : 2015-10-26 :
|
Recruiting |
: Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy : Bile Duct Cancer : 2010-12-07 : Dietary Supplement: Oral IMPACT oral supplement for 5 days(1L/day) before surgery of a formula enriched |
Recruiting |
: CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery :
: Drug: 6,8-bis(benzylthio)octanoic acid Given IV Othe |
Recruiting |
: Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer :
: |
Enrolling by invitation |
: Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer :
: 2009-03-31 : Drug: Cox2 inhibitor (Celecoxib) From postoperative third day, administration will be started celecoxib |